Clinical Pharmacology and Drug Toxicity Practice Questions

Q: What is the primary treatment approach for organophosphate poisoning?

Atropine and pralidoxime. ***Atropine and pralidoxime*** - **Atropine** is primarily used to block the muscarinic effects of **acetylcholine** excess, such as **bradycardia**, **bronchospasm**, and excessive secretions. - **Pralidoxime** (2-PAM) is an **acetylcholinesterase reactivator** that can reverse both muscarinic and nicotinic effects by detaching the organophosphate from the enzyme. *Activated charcoal* - While generally used for decontamination in many poisonings, **activated charcoal** is primarily effective in the early stages (within 1-2 hours) after ingestion for substances that undergo enterohepatic recirculation. - Its role in moderate to severe **organophosphate poisoning** is limited once systemic absorption has occurred. *Sodium bicarbonate* - **Sodium bicarbonate** is primarily used to treat **metabolic acidosis** or to alkalinize urine in certain drug overdoses to enhance excretion. - It does not directly counteract the pharmacological effects of **organophosphate poisoning**. *Dialysis* - **Dialysis** is a procedure used to remove toxins from the blood in cases of **renal failure** or poisoning by substances with specific characteristics (e.g., low molecular weight, low protein binding). - Most **organophosphates** are not effectively removed by dialysis due to their lipid solubility and rapid distribution into tissues.

Q: In a case of suspected opioid overdose, what is the primary physiological mechanism that leads to death?

Respiratory depression. ***Respiratory depression*** - Opioids act on **mu-opioid receptors** in the brainstem, leading to a decreased sensitivity of the respiratory center to **carbon dioxide**. - This results in a reduced respiratory rate and tidal volume, progressing to **hypoventilation**, **hypoxia**, and ultimately **respiratory arrest**. - This is the **primary and most critical mechanism** of death in acute opioid overdose. *Cardiac arrhythmia* - While opioids can have cardiovascular effects, **cardiac arrhythmias** are not the primary direct cause of death in acute opioid overdose. - Severe hypoxia resulting from respiratory depression can secondarily lead to cardiac dysfunction, but it's not the initial mechanism of death. *Hypothermia* - Opioids can cause **hypothermia** by affecting thermoregulation, but it is typically not the direct and primary cause of death. - The drop in body temperature usually follows respiratory compromise, or it might exacerbate the situation rather than being the fatal event itself. *Severe dehydration* - **Severe dehydration** is not a characteristic immediate effect of acute opioid overdose. - Opioid use can lead to constipation, but significant fluid loss leading to death is not a primary acute overdose mechanism.

Q: In organophosphate (OP) poisoning, which treatment is prioritized?

Atropine. ***Atropine*** - **Atropine** is the **FIRST-LINE and priority treatment** for organophosphate (OP) poisoning. - It competitively blocks **muscarinic receptors**, rapidly reversing life-threatening symptoms: **bronchospasm**, **bronchorrhea**, **bradycardia**, **salivation**, and **miosis**. - Administered in **high and repeated doses** until **atropinization** is achieved (dry skin, tachycardia, mydriasis). - **Critical for immediate stabilization** and can be life-saving within minutes of administration. *Pralidoxime (2-PAM)* - **Pralidoxime** is an important **adjunctive therapy** given after or alongside atropine. - It is a **cholinesterase reactivator** that detaches organophosphate from acetylcholinesterase, restoring enzyme function. - Most effective when given **early** (within 24-48 hours) before **aging** of the enzyme-organophosphate complex occurs. - Addresses **nicotinic effects** (muscle weakness, fasciculations) that atropine does not treat, but is not the priority in acute management. *Activated charcoal* - Can be used for **gastrointestinal decontamination** if ingestion occurred within 1-2 hours. - **Not a priority** compared to specific antidotes, and effectiveness is limited by rapid absorption of organophosphates. *Gastric lavage* - Involves flushing the stomach to remove ingested toxins. - **Rarely recommended** in modern practice due to risk of complications (aspiration, esophageal perforation). - Not appropriate in OP poisoning unless the patient is intubated and lavage can be performed safely within 1 hour of ingestion.

Q: In a case of suspected drug overdose, a 28-year-old male presents with dilated pupils, hyperthermia, and agitation. Which substance is most likely involved?

Cocaine. ***Cocaine*** - **Cocaine overdose** commonly presents with a **sympathomimetic toxidrome**, characterized by **dilated pupils (mydriasis)**, **hyperthermia**, and significant **agitation**. - This substance is a powerful stimulant that increases synaptic norepinephrine, serotonin, and dopamine, leading to widespread stimulatory effects on the central and peripheral nervous systems. *Opiates* - Opiate overdose typically causes the opposite effects: **pupillary constriction (miosis)**, **respiratory depression**, and **CNS depression** leading to somnolence or coma. - While agitation can occur during withdrawal, the initial overdose profile is overwhelmingly depressant. *Benzodiazepines* - Benzodiazepine overdose primarily causes **CNS depression**, including **sedation**, **ataxia**, and **respiratory depression**, but does not typically cause pupillary dilation or hyperthermia. - Pupils are usually normal or slightly constricted, and vital signs are generally depressed rather than stimulated. *Alcohol* - Acute alcohol intoxication primarily leads to **CNS depression**, characterized by ataxia, slurred speech, sedation, and potentially respiratory depression or coma at high doses. - While agitation can occur, pupillary dilation and hyperthermia are not typical features; pupils are usually normal or slightly dilated in severe cases, and body temperature tends to drop.

Q: Why is isotretinoin reserved for severe cases of acne?

It has significant side effects, including teratogenicity.. **It has significant side effects, including teratogenicity.** - **Isotretinoin** is a potent medication with numerous potential side effects, including severe **teratogenicity**, which mandates strict contraception for female patients of childbearing potential. - Other common side effects include **dry skin**, **mucous membranes**, and potential liver, lipid, and psychiatric effects, justifying its use primarily in severe, recalcitrant acne. *It is less effective than other treatments* - This statement is incorrect; **isotretinoin** is highly effective, often leading to long-term remission or even cure of **severe acne**, frequently outperforming other treatments. - Its efficacy in reducing **sebum production**, inflammation, and comedone formation is superior to most topical and systemic therapies. *It is difficult to administer* - **Isotretinoin** is administered orally, typically once or twice daily, which is a relatively straightforward method of administration. - The complexity lies more in the **monitoring requirements** (e.g., blood tests for lipids and liver function) and regulatory programs like iPLEDGE in the U.S. to prevent teratogenicity, rather than the act of taking the pill itself. *It only works for a short period* - This is incorrect; **isotretinoin** often provides **long-lasting remission** or even a permanent cure for acne, even after a single course of treatment. - While some patients may require a second course, the **duration of its therapeutic effect** is generally prolonged, making it a very effective long-term solution for many.

Q: Which medication increases the risk of kernicterus in newborns with unconjugated hyperbilirubinemia?

Sulphonamide. ***Sulphonamide*** - **Sulphonamides** are the **classic example** of drugs that compete with **bilirubin** for binding sites on **albumin**, displacing bilirubin and increasing the amount of **unbound bilirubin** in the circulation. - This increased **free unconjugated bilirubin** can cross the immature **blood-brain barrier** of newborns, leading to **kernicterus**. - **Sulphonamides** are well-documented in medical literature and **contraindicated in neonates** for this reason. *Ceftriaxone* - **Ceftriaxone** also displaces **bilirubin** from **albumin binding sites** and is **contraindicated** in neonates with hyperbilirubinemia due to the risk of **kernicterus**. - While both ceftriaxone and sulphonamides share this mechanism, **sulphonamides** are the **traditional textbook answer** for questions about drug-induced kernicterus risk. - The FDA specifically warns against using ceftriaxone in neonates with jaundice. *Phenobarbitone* - **Phenobarbitone** actually helps to *reduce* **bilirubin levels** by inducing **hepatic enzymes** involved in **bilirubin conjugation and excretion**. - This effect makes it a therapeutic option for certain types of **neonatal jaundice**, not a risk factor for **kernicterus**. *Ampicillin* - **Ampicillin** is an **antibiotic** that does not significantly affect **bilirubin metabolism** or displacement from **albumin**. - It is not associated with an increased risk of **kernicterus** in newborns.

Q: Why is bupivacaine contraindicated in patients with a history of cardiac arrhythmias?

It can cause severe cardiotoxicity. ***It can cause severe cardiotoxicity*** - Bupivacaine is known for its potential to cause **severe cardiotoxicity**, including **ventricular arrhythmias**, **bradycardia**, and **cardiac arrest**, especially at higher doses or in susceptible individuals. - Patients with a history of **cardiac arrhythmias** are more vulnerable to these cardiotoxic effects due to their pre-existing myocardial instability, making bupivacaine a relative or absolute contraindication. - Bupivacaine has high affinity for **cardiac sodium channels** and prolonged dissociation, leading to cumulative myocardial depression and arrhythmias. *It is not effective for regional anesthesia* - This statement is incorrect; **bupivacaine** is a highly effective and commonly used local anesthetic for **regional anesthesia** due to its prolonged duration of action. - Its efficacy in providing **nerve blocks** and **epidural anesthesia** is well-established in clinical practice. *It causes significant sedation* - While some local anesthetics can cause mild central nervous system (CNS) effects, **bupivacaine** is not typically associated with **significant sedation** at therapeutic doses. - **CNS toxicity** usually manifests as excitation (e.g., tremors, seizures) before depression in cases of overdose or systemic absorption. *It has a slow onset of action* - While **bupivacaine** does have a relatively **slower onset of action** compared to some other local anesthetics (e.g., lidocaine), this is a **pharmacokinetic property**, not a contraindication. - The slower onset is often accepted in exchange for its **longer duration of action** (3-8 hours), which is desirable for prolonged surgical procedures and postoperative analgesia. - Onset time is not a safety concern in patients with cardiac arrhythmias.

Q: Which drug is used to treat cyanide poisoning by converting cyanide to a less toxic compound?

Sodium thiosulfate. ***Sodium thiosulfate*** - **Sodium thiosulfate** acts as a sulfur donor, which allows the enzyme **rhodanase** to convert **cyanide** into the less toxic compound **thiocyanate**. - This reaction aids in the detoxification and subsequent excretion of cyanide from the body. *Pralidoxime* - **Pralidoxime** is primarily used to treat poisoning by **organophosphates** by reactivating **acetylcholinesterase**. - It has no direct role in the detoxification pathway of cyanide. *Atropine* - **Atropine** is an anticholinergic agent used to counteract the muscarinic effects of **organophosphate poisoning**. - It does not have any mechanism of action that deactivates or converts cyanide. *Deferoxamine* - **Deferoxamine** is a **chelating agent** primarily used to treat **iron overload** or **iron poisoning**. - It binds to iron to form a stable complex that can be excreted, and has no efficacy in cyanide poisoning.

Q: Which of the following is the drug of choice for the treatment of neuroleptic malignant syndrome?

Dantrolene. ***Dantrolene*** - **Dantrolene** is a **direct-acting skeletal muscle relaxant** that works by inhibiting calcium release from the sarcoplasmic reticulum, thus reducing muscle rigidity and hyperthermia. - Among the given options, it is the **most appropriate choice** for treating **neuroleptic malignant syndrome (NMS)**, particularly when severe muscle rigidity and hyperthermia are present. - **Note:** In clinical practice, **bromocriptine** (a dopamine agonist) is often considered first-line pharmacotherapy as it reverses the underlying dopamine blockade. Dantrolene is typically used as **adjunctive therapy** or when bromocriptine is unavailable, though it remains highly effective for the hypermetabolic muscle crisis. *Haloperidol* - **Haloperidol** is a typical **antipsychotic** that blocks dopamine D2 receptors and is one of the drugs most commonly implicated in **causing NMS**, not treating it. - Administering haloperidol would exacerbate the underlying dopamine blockade pathology and significantly worsen the patient's condition. *Chlorpromazine* - **Chlorpromazine** is another typical **antipsychotic** that causes significant dopamine blockade and is also associated with precipitating NMS. - Its use would worsen NMS symptoms rather than treat them, as continued antipsychotic administration perpetuates the syndrome. *Lorazepam* - **Lorazepam** is a **benzodiazepine** that can help manage agitation, anxiety, and muscle spasms in NMS as **supportive care**. - While useful as an **adjunctive treatment**, it does not address the core pathophysiology of dopamine blockade or the massive muscle contraction and hyperthermia characteristic of NMS. - It plays a supportive role but is not the primary pharmacological intervention.

Q: A 30-year-old woman with rheumatoid arthritis who is on methotrexate therapy presents with shortness of breath. What is the most likely explanation for this patient's respiratory symptoms?

Pulmonary fibrosis. ***Pulmonary fibrosis*** - Methotrexate can cause **interstitial lung disease**, including **pulmonary fibrosis**, which manifests as shortness of breath and cough due to inflammation and scarring of lung tissue. - Rheumatoid arthritis itself can also lead to **interstitial lung disease**, making patients on methotrexate particularly susceptible to respiratory complications. *Hepatotoxicity* - Methotrexate can cause **liver damage**, leading to elevated liver enzymes and, rarely, cirrhosis, but this would not directly cause **shortness of breath**. - While significant liver dysfunction can impact overall health, respiratory symptoms are not a primary and direct manifestation of isolated hepatotoxicity. *Nephrotoxicity* - Methotrexate is primarily cleared by the kidneys, and high doses can cause **kidney damage** leading to acute kidney injury, but this would not cause **shortness of breath**. - Renal impairment might complicate methotrexate elimination, but direct respiratory symptoms are not a typical presentation of nephrotoxicity. *Gastrointestinal bleeding* - Methotrexate can cause gastrointestinal side effects such as nausea, vomiting, and mucositis, and rarely, gastrointestinal ulceration and bleeding, but this would not primarily present as **shortness of breath**. - While severe anemia from significant GI bleeding could cause dyspnea, it is not the most direct or common respiratory complication from methotrexate therapy in this context.

Question 1

What is the primary treatment approach for organophosphate poisoning?

Accepted Answer

Atropine and pralidoxime

Answer

Activated charcoal

Answer

Sodium bicarbonate

Answer

Dialysis

Question 2

In a case of suspected opioid overdose, what is the primary physiological mechanism that leads to death?

Accepted Answer

Respiratory depression

Answer

Cardiac arrhythmia

Answer

Hypothermia

Answer

Severe dehydration

Question 3

In organophosphate (OP) poisoning, which treatment is prioritized?

Accepted Answer

Atropine

Answer

Activated charcoal

Answer

Gastric lavage

Answer

Pralidoxime (2-PAM)

Question 4

In a case of suspected drug overdose, a 28-year-old male presents with dilated pupils, hyperthermia, and agitation. Which substance is most likely involved?

Accepted Answer

Cocaine

Answer

Opiates

Answer

Benzodiazepines

Answer

Alcohol

Question 5

Why is isotretinoin reserved for severe cases of acne?

Accepted Answer

It has significant side effects, including teratogenicity.

Answer

It is less effective than other treatments

Answer

It is difficult to administer

Answer

It only works for a short period

Question 6

Which medication increases the risk of kernicterus in newborns with unconjugated hyperbilirubinemia?

Accepted Answer

Sulphonamide

Answer

Ceftriaxone

Answer

Phenobarbitone

Answer

Ampicillin

Question 7

Why is bupivacaine contraindicated in patients with a history of cardiac arrhythmias?

Accepted Answer

It can cause severe cardiotoxicity

Answer

It is not effective for regional anesthesia

Answer

It causes significant sedation

Answer

It has a slow onset of action

Question 8

Which drug is used to treat cyanide poisoning by converting cyanide to a less toxic compound?

Accepted Answer

Sodium thiosulfate

Answer

Pralidoxime

Answer

Atropine

Answer

Deferoxamine

Question 9

Which of the following is the drug of choice for the treatment of neuroleptic malignant syndrome?

Accepted Answer

Dantrolene

Answer

Haloperidol

Answer

Chlorpromazine

Answer

Lorazepam

Question 10

A 30-year-old woman with rheumatoid arthritis who is on methotrexate therapy presents with shortness of breath. What is the most likely explanation for this patient's respiratory symptoms?

Accepted Answer

Pulmonary fibrosis

Answer

Hepatotoxicity

Answer

Nephrotoxicity

Answer

Gastrointestinal bleeding

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?